Virtual ISPOR-FDA Summit 2020: Using Patient-Preference Information in Medical Device Regulatory Decisions: Benefit-Risk and Beyond
The ISPOR and US Food and Drug Administration (FDA) Center for Devices and Radiological Health (CDRH) jointly sponsored Summit will be held virtually. The one-day Virtual ISPOR-FDA Summit 2020 focusing on medical devices and the use of patient-preference information (PPI) in regulatory and other decision-making processes is now on September 29, 2020.
Key Objectives for discussion at the Summit are:
- To provide a forum for engaging all stakeholders including patient representatives, medical device industry, researchers, payers and policymakers, healthcare providers, assessors, and regulators to discuss and explore the role, challenges, and opportunities of using PPI.
- To identify possible barriers and highlight the opportunities for integrating PPI throughout the product lifecycle.
- To clarify the value of including PPI in regulatory, reimbursement, and patient-provider decision-making processes.